Related Experiment Video

Updated: Aug 12, 2026

Construction of a Wireless-Enabled Endoscopically Implantable Sensor for pH Monitoring with Zero-Bias Schottky Diode-based Receiver
08:25

Construction of a Wireless-Enabled Endoscopically Implantable Sensor for pH Monitoring with Zero-Bias Schottky Diode-based Receiver

Published on: August 27, 2021

Use of bethanechol for the treatment of gastroesophageal reflux

A R Euler

    The Journal of Pediatrics
    |February 1, 1980
    PubMed

    Insights

    Bethanechol significantly improved gastroesophageal reflux in pediatric patients. Infants and older children showed clinical benefits, with reduced reflux episodes and duration, suggesting it as a viable treatment option.

    Area of Science:

    • Pediatric Gastroenterology
    • Pharmacology
    • Clinical Medicine

    Background:

    • Gastroesophageal reflux is common in pediatric patients.
    • Conventional therapies do not always provide sufficient relief.

    Purpose of the Study:

    • To evaluate the efficacy of bethanechol in treating pediatric gastroesophageal reflux.
    • To assess the drug's impact on reflux episodes and related physiological parameters.

    Main Methods:

    • A double-blind, crossover study was conducted.
    • 45 pediatric patients with gastroesophageal reflux participated.
    • Bethanechol treatment was compared against a placebo.

    Main Results:

    • Significant clinical improvement was observed in both infants (<1 year) and older children (>1 year) on bethanechol compared to placebo.
    • Esophageal pH monitoring showed a significant decrease in the frequency and duration of reflux episodes.
    • Esophageal manometrics indicated increased lower esophageal sphincter pressure and peristaltic activity.

    Conclusions:

    • Bethanechol demonstrates significant efficacy in improving pediatric gastroesophageal reflux.
    • The drug may improve reflux by enhancing lower esophageal sphincter pressure and esophageal motility.
    • Bethanechol is a potential therapeutic option for pediatric patients unresponsive to conventional treatments.

    More Related Videos

    Robotic Myotomy and Partial Fundoplication for Achalasia11:19

    Robotic Myotomy and Partial Fundoplication for Achalasia

    Published on: August 11, 2023

    Endoscopic Vacuum Therapy for the Treatment of Anastomotic Leakage after Total Gastrectomy with Esophagojejunostomy04:05

    Endoscopic Vacuum Therapy for the Treatment of Anastomotic Leakage after Total Gastrectomy with Esophagojejunostomy

    Published on: August 22, 2025

    Related Concept Videos

    Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

    Direct-Acting Cholinergic Agonists: Therapeutic Uses

    Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
    Drugs for Treatment of Constipation-Predominant IBS01:21

    Drugs for Treatment of Constipation-Predominant IBS

    Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
    Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

    Gastroesophageal Reflux Disease II: Clinical Features and Management

    Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
    Clinical Manifestations
    GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
    Barrett Esophagus-II: Clinical Manifestations and Management01:21

    Barrett Esophagus-II: Clinical Manifestations and Management

    Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
    To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
    Peptic Ulcer Disease IV: Management01:26

    Peptic Ulcer Disease IV: Management

    Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
    The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
    Pharmacological management
    The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
    Gastroesophageal Reflux Disease01:25

    Gastroesophageal Reflux Disease

    Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...